-
-
-
-
-
-
-
Ipsen Announces Onivyde Regimen Demonstrated Statistically Significant Improvement in OS in Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma
-
-
-
-
-
-
-
Merrimack Reports Third Quarter 2021 Financial Results
-
-
-
-
-
-
-
Merrimack Receives $5 Million Milestone Payment from Ipsen; Declares $6.7 Million Special Dividend
-
-
-
-
-
-
-
Merrimack Pharma (MACK) Misses Q3 EPS by 65c, Initiate Corporate Restructuring
-
-
-
-
-
-
-
Merrimack Reports Second Quarter 2018 Financial Results
-
-
-
-
-
-
-
Merrimack Announces Timing of Full Year 2017 Investor Conference Call and Presentation at the Cowen Health Care Conference
-
-
-
-
-
-
-
Merrimack Announces Timing of Second Quarter 2017 Investor Conference Call
-
1,198,614 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

